Faber, S.C.; Lahoti, T.S.; Taylor, E.R.; Lewis, L.; Sapiro, J.M.; Toledo Sales, V.; Dragan, Y.P.; Jeffy, B.D.
Current Therapeutic Landscape and Safety Roadmap for Targeting the Aryl Hydrocarbon Receptor in Inflammatory Gastrointestinal Indications. Cells 2022, 11, 1708.
https://doi.org/10.3390/cells11101708
AMA Style
Faber SC, Lahoti TS, Taylor ER, Lewis L, Sapiro JM, Toledo Sales V, Dragan YP, Jeffy BD.
Current Therapeutic Landscape and Safety Roadmap for Targeting the Aryl Hydrocarbon Receptor in Inflammatory Gastrointestinal Indications. Cells. 2022; 11(10):1708.
https://doi.org/10.3390/cells11101708
Chicago/Turabian Style
Faber, Samantha C., Tejas S. Lahoti, Ewan R. Taylor, Lauren Lewis, Jessica M. Sapiro, Vicencia Toledo Sales, Yvonne P. Dragan, and Brandon D. Jeffy.
2022. "Current Therapeutic Landscape and Safety Roadmap for Targeting the Aryl Hydrocarbon Receptor in Inflammatory Gastrointestinal Indications" Cells 11, no. 10: 1708.
https://doi.org/10.3390/cells11101708
APA Style
Faber, S. C., Lahoti, T. S., Taylor, E. R., Lewis, L., Sapiro, J. M., Toledo Sales, V., Dragan, Y. P., & Jeffy, B. D.
(2022). Current Therapeutic Landscape and Safety Roadmap for Targeting the Aryl Hydrocarbon Receptor in Inflammatory Gastrointestinal Indications. Cells, 11(10), 1708.
https://doi.org/10.3390/cells11101708
